Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
Title:
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
Author:
Ravandi, Farhad Assi, Rita Daver, Naval Benton, Christopher B Kadia, Tapan Thompson, Philip A Borthakur, Gautam Alvarado, Yesid Jabbour, Elias J Konopleva, Marina Takahashi, Koichi Kornblau, Steven DiNardo, Courtney D Estrov, Zeev Flores, Wilmer Basu, Sreyashi Allison, James Sharma, Padmanee Pierce, Sherry Pike, Allison Cortes, Jorge E Garcia-Manero, Guillermo Kantarjian, Hagop M